Fountzilas, E.; Papadopoulou, K.; Chatzikonstantinou, T.; Karakatsoulis, G.; Constantoulakis, P.; Tsantikidi, A.; Tsaousis, G.; Karageorgopoulou, S.; Koumarianou, A.; Mauri, D.;
et al. Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer. Cancers 2023, 15, 5525.
https://doi.org/10.3390/cancers15235525
AMA Style
Fountzilas E, Papadopoulou K, Chatzikonstantinou T, Karakatsoulis G, Constantoulakis P, Tsantikidi A, Tsaousis G, Karageorgopoulou S, Koumarianou A, Mauri D,
et al. Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer. Cancers. 2023; 15(23):5525.
https://doi.org/10.3390/cancers15235525
Chicago/Turabian Style
Fountzilas, Elena, Kyriaki Papadopoulou, Thomas Chatzikonstantinou, Georgios Karakatsoulis, Pantelis Constantoulakis, Aikaterini Tsantikidi, Georgios Tsaousis, Sofia Karageorgopoulou, Anna Koumarianou, Davide Mauri,
and et al. 2023. "Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer" Cancers 15, no. 23: 5525.
https://doi.org/10.3390/cancers15235525
APA Style
Fountzilas, E., Papadopoulou, K., Chatzikonstantinou, T., Karakatsoulis, G., Constantoulakis, P., Tsantikidi, A., Tsaousis, G., Karageorgopoulou, S., Koumarianou, A., Mauri, D., Ntavatzikos, A., Saridaki, Z., Petrakis, G., Fostira, F., Fountzilas, G., & Liontos, M.
(2023). Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer. Cancers, 15(23), 5525.
https://doi.org/10.3390/cancers15235525